Fundraising Fox

EXPIN

New York City, US · 1 known investors

EXPIN develops AI-driven tools for clinicians to analyze exposome data—the lifetime accumulation of environmental, chemical, and lifestyle exposures—to enable precision medicine for chronic disease prevention and treatment. The company serves healthcare providers and patients seeking to understand how non-genetic factors drive disease at the molecular level.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Founders & leadership

KBKrisna Bhargava
Krisna BhargavainFounder & CEO
JF
Jonathan FreedmanHead of Science
UG
Uta GuoHead of Medicine

Investors · 1

Dria VenturesNew Yorkvia Megan Maloney · inferred

Frequently asked questions

What does EXPIN do?
EXPIN develops AI-driven tools for clinicians to analyze exposome data—the lifetime accumulation of environmental, chemical, and lifestyle exposures—to enable precision medicine for chronic disease prevention and treatment. The company serves healthcare providers and patients seeking to understand how non-genetic factors drive disease at the molecular level.
Who founded EXPIN?
EXPIN was founded by Krisna Bhargava.
Who are EXPIN's investors?
EXPIN's investors include Dria Ventures.
Where is EXPIN headquartered?
EXPIN is headquartered in New York City, US.